Differential regulation of kidney and spleen cytokine responses in mice challenged with pathology-standardized doses of Candida albicans mannosylation mutants
- PMID: 21059878
- PMCID: PMC3019922
- DOI: 10.1128/IAI.01004-10
Differential regulation of kidney and spleen cytokine responses in mice challenged with pathology-standardized doses of Candida albicans mannosylation mutants
Abstract
Cell surface polysaccharides are key determinants of host responses to fungal infection. We determined the effects of alterations in Candida albicans cell surface polysaccharide composition and gross changes in the host immune response in groups of mice challenged intravenously with five C. albicans strains at doses adjusted to give equal disease progression 3 days later. The five strains used were the parental strain NGY152, two mutants with defective cell wall mannosylation, pmr1Δ mutant and mnt1/2Δ mutant, and the same two strains with a copy of PMR1 and MNT1 reintegrated, respectively. Renal and spleen levels of chemokines and cytokines previously shown to be key components of early host response to C. albicans were determined at intervals up to 3 days after challenge. By 12 h after C. albicans challenge, the levels of granulocyte colony-stimulating factor (G-CSF), keratinocyte-derived chemokine (KC), interleukin 6 (IL-6), monocyte chemotactic peptide 1 (MCP-1), macrophage inflammatory protein 1α (MIP-1α), MIP-1β, and MIP-2 were higher in the kidneys of mice challenged with the pmr1Δ mutant than in animals challenged with the other strains and were lower by day 3, suggesting an earlier host response to the pmr1Δ mutant. The production of these chemokines also diminished earlier than controls in mice infected with the mnt1/2Δ strain. Although these differences were statistically significant, their magnitude was seldom great, and no unambiguous evidence was obtained for individual responses specific to any cell surface glycosylation change. We conclude that complex, multifactorial local responses offset and obscure any differences resulting from differences in surface mannosylation of C. albicans strains when infection results from pathology-standardized challenges.
Figures
Similar articles
-
Involvement of mannose receptor in cytokine interleukin-1beta (IL-1beta), IL-6, and granulocyte-macrophage colony-stimulating factor responses, but not in chemokine macrophage inflammatory protein 1beta (MIP-1beta), MIP-2, and KC responses, caused by attachment of Candida albicans to macrophages.Infect Immun. 1997 Mar;65(3):1077-82. doi: 10.1128/IAI.65.3.1077-1082.1997. Infect Immun. 1997. PMID: 9038318 Free PMC article.
-
Early-expressed chemokines predict kidney immunopathology in experimental disseminated Candida albicans infections.PLoS One. 2009 Jul 29;4(7):e6420. doi: 10.1371/journal.pone.0006420. PLoS One. 2009. PMID: 19641609 Free PMC article.
-
Urea amidolyase (DUR1,2) contributes to virulence and kidney pathogenesis of Candida albicans.PLoS One. 2012;7(10):e48475. doi: 10.1371/journal.pone.0048475. Epub 2012 Oct 29. PLoS One. 2012. PMID: 23144764 Free PMC article.
-
Candida albicans cell wall glycans, host receptors and responses: elements for a decisive crosstalk.Curr Opin Microbiol. 2004 Aug;7(4):342-9. doi: 10.1016/j.mib.2004.06.011. Curr Opin Microbiol. 2004. PMID: 15358252 Review.
-
Mannosylation in Candida albicans: role in cell wall function and immune recognition.Mol Microbiol. 2013 Dec;90(6):1147-61. doi: 10.1111/mmi.12426. Epub 2013 Nov 8. Mol Microbiol. 2013. PMID: 24125554 Free PMC article. Review.
Cited by
-
Role of Candida albicans secreted aspartyl protease Sap9 in interkingdom biofilm formation.Pathog Dis. 2016 Apr;74(3):ftw005. doi: 10.1093/femspd/ftw005. Epub 2016 Jan 14. Pathog Dis. 2016. PMID: 26772652 Free PMC article.
-
Specific Human and Candida Cellular Interactions Lead to Controlled or Persistent Infection Outcomes during Granuloma-Like Formation.Infect Immun. 2016 Dec 29;85(1):e00807-16. doi: 10.1128/IAI.00807-16. Print 2017 Jan. Infect Immun. 2016. PMID: 27799331 Free PMC article.
-
Elevated cell wall chitin in Candida albicans confers echinocandin resistance in vivo.Antimicrob Agents Chemother. 2012 Jan;56(1):208-17. doi: 10.1128/AAC.00683-11. Epub 2011 Oct 10. Antimicrob Agents Chemother. 2012. PMID: 21986821 Free PMC article.
-
A novel renal epithelial cell in vitro assay to assess Candida albicans virulence.Virulence. 2014 Feb 15;5(2):286-96. doi: 10.4161/viru.27046. Epub 2013 Nov 13. Virulence. 2014. PMID: 24225657 Free PMC article.
-
Investigation of OCH1 in the Virulence of Candida parapsilosis Using a New Neonatal Mouse Model.Front Microbiol. 2017 Jun 30;8:1197. doi: 10.3389/fmicb.2017.01197. eCollection 2017. Front Microbiol. 2017. PMID: 28713338 Free PMC article.
References
-
- Bates, S., D. M. MacCallum, G. Bertram, C. A. Munro, H. B. Hughes, E. T. Buurman, A. J. P. Brown, F. C. Odds, and N. A. R. Gow. 2005. Candida albicans Pmr1p, a secretory pathway P-type Ca2+/Mn2+-ATPase, is required for glycosylation and virulence. J. Biol. Chem. 280:23408-23415. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous